Articles

Pharma Pulse 6/20/25: Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success; Innovation Requires Investment—and Sustained Investment Requires Sufficient Returns

A cross-sectional study investigates whether becoming eligible for Medicare at age 65 is linked to changes in healthcare use among individuals experiencing mental health challenges.

How Medicare Eligibility Affects Healthcare Use in Adults with Psychological Distress

Videos

In the third part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, explains how a flat admin fee model can potentially create more value for both payers and patients.

Establishing Additional Transparency

Pharma Pulse 6/19/25: Strategic Planning in the Rebate Economy; The Truth About AI Adoption Speed in Clinical Research

Is Medicare plan switching influenced by initial type of Medicare coverage and cancer history?

The Impact of Initial Coverage Choice

The 200,000 square-foot Madison, WI facility will serve as the flagship location, with capabilities for future growth. 

TekniPlex Healthcare Unveils New Barrier Protection Systems Plant

In the second part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, discusses how this MFN executive order can affect players in the space that operate under a rebate-driven PBM model. 

Moving Beyond the Rebate-Driven Model

Pharma Pulse 6/18/25: The Complexities of Drug Discounting; How Clinical Operations Teams Are Adapting to Oncology Trial Challenges

Though this specific agreement centers around aerospace and automobiles, the greater supply chain will wait and see how Trump’s import taxes impact pharmaceuticals, a sector that faces a potential 25% tax on imports.

United States, United Kingdom Reach Tariff-Lowering Deal

In the first part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, outlines the most critical root causes of rising healthcare and drug costs that the MFN executive order doesn’t address.

News